Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women

BACKGROUND: Methamphetamine (MA) use during pregnancy is associated with many pregnancy complications, including preterm birth, small for gestational age, preeclampsia, and abruption. Hawaii has lead the nation in MA use for many years, yet prior to 2007, did not have a comprehensive plan to care fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Tricia E, Schuetter, Renee, Fombonne, Eric, Stephenson, Jessica, Haning, William F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292917/
https://www.ncbi.nlm.nih.gov/pubmed/22260315
http://dx.doi.org/10.1186/1477-7517-9-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292917/
https://www.ncbi.nlm.nih.gov/pubmed/22260315
http://dx.doi.org/10.1186/1477-7517-9-5

Ejemplares similares